- Home
- JKS vs QURE Comparison
JKS vs QURE Comparison
Compare JKS & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JKS | QURE |
|---|---|---|
| Founded | 2006 | 1998 |
| Country | China | Netherlands |
| Employees | N/A | 248 |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2010 | 2013 |
Fundamental Metrics
Financial Performance| Metric | JKS | QURE |
|---|---|---|
| Price | $23.58 | $24.34 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 14 |
| Target Price | $24.80 | ★ $45.00 |
| AVG Volume (30 Days) | 715.8K | ★ 2.0M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 6.04% | N/A |
| EPS Growth | N/A | ★ 29.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $13,107,000.00 |
| Revenue This Year | N/A | $126.12 |
| Revenue Next Year | $14.60 | $200.43 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $17.53 | $8.73 |
| 52 Week High | $31.88 | $71.50 |
Technical Indicators
Market Signals| Indicator | JKS | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 49.59 | 57.67 |
| Support Level | $21.44 | $21.16 |
| Resistance Level | $24.17 | $25.66 |
| Average True Range (ATR) | 1.44 | 2.15 |
| MACD | -0.14 | -0.37 |
| Stochastic Oscillator | 42.03 | 44.73 |
Price Performance
Historical ComparisonAbout JKS JinkoSolar Holding Company Limited (each representing 4)
JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), the Americas, Europe, Asia Pacific, and the Rest of the world.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.